COIMBRA, Portugal, June 26, 2017 /PRNewswire/ -- At the
16th International Photodynamic Association (IPA) World
Congress in Coimbra, Professor Michael
Wilson was the recipient of the 2017 LIFETIME ACHIEVEMENT
AWARD IN ANTIMICROBIAL PDT RESEARCH. Professor Wilson is Emeritus
Professor of Microbiology at the Eastman Dental Institute in the
Faculty of Medical Services of University College London (UCL).
Professor Michael Wilson is
accredited with the re-introduction of antimicrobial PDT to modern
day practice. He was the first to successfully treat complex
biofilm infections using antimicrobial PDT, demonstrating the
potency of this technology against multidrug-resistant
pathogens.
Photo -
http://mma.prnewswire.com/media/527765/Professor_Michael_Wilson.jpg
One of the greatest problems facing modern medicine is the
growing resistance of microbes to antibiotics. Professor Wilson,
having monitored the prevalence of antibiotic-resistant organisms
and the genetic basis for their resistance, had developed new
antimicrobial strategies (including light-activated antimicrobial
agents) to supplement humanity's dwindling supply of agents that
can be used to treat infectious diseases. Professor Wilson's work
focused on the structure and physiology of bacteria in biofilms and
in the development of strategies for preventing biofilm-associated
diseases, including the use of antimicrobial PDT. Professor
Wilson's contributions were seminal to the commercial development
of antimicrobial PDT that has resulted in more than 300,000
patients treated globally. Professor Wilson continues to lecture,
write and support antimicrobial PDT technology, products and
applications, lending his critical endorsement to assist with
global adoption and sustainability of this non-antibiotic
antimicrobial therapy.
The Coimbra World Congress was the 16th conference
held by the International Photodynamic Association, marking 32
years of this global meeting. The IPA World Congresses, held every
two years, are the leading PDT meetings bringing together members
of the global photodynamic community in order to advance scientific
and clinical research relating to photodiagnosis and photodynamic
therapies. The next IPA World Congress is to be hosted in
Boston, USA and will be led by Dr. Tayyaba Hasan, Professor of Dermatology at the
Wellman Center for Photomedicine, Harvard
Medical School (HMS) and a Professor of Health Sciences and
Technology (Harvard-MIT).
About Photodynamic Therapy (PDT)
Photodynamic Therapy (PDT) is a combination therapy involving
light activated photosensitizers to diagnose and treat various
types of cancers and pre-cancers, macular degeneration and
multidrug resistant biofilm infections involving bacteria, viruses
and fungi.
CONTACT: ipasecretary@internationalphotodynamic.com